Trial intelligence / Profile preview

PENTRIOX: Oxidative Stress from Penicillin V and Trimethoprim

NCT02188472Phase 1Completed

Start
Nov 2010
Primary completion
Feb 2011
Modality
Reversible Covalent Inhibitors
Countries
1
01

Overview

Phase 1, randomised, double-blind trial of phenoxymethylpenicillin and trimethoprim in bacterial infection. Primary endpoint: Urinary excretion of 8-oxoguanosine at 7 days. Started Nov 2010; status: completed.

02

Drugs

phenoxymethylpenicillintrimethoprim
03

Conditions

bacterial infection

Beyond the preview

Go deeper on NCT02188472.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02188472.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call